TGF-β Receptor

TGF-β 受体(转化生长因子-β 受体)是单向丝氨酸/苏氨酸激酶受体。转化生长因子 β (TGF-β) 是多效性细胞因子大家族的成员,参与许多生物过程,包括正常和患病状态下的生长控制、分化、迁移、细胞存活、粘附和发育命运的指定。TGF-β 超家族成员通过由 II 型和 I 型受体(均为丝氨酸/苏氨酸激酶)组成的受体复合物发出信号。

I 型受体称为激活素受体样激酶 (ALK),位于信号级联的中心,因为它们将 TGF-β 信号传导至称为 Smad 蛋白的细胞内转录调节剂。ALK 具有胞外结合结构域、跨膜结构域、作为 II 型受体激活位点的 GS 结构域以及激活下游信号分子的激酶结构域。ALK 介导 TGF-β 超家族对增殖、分化、凋亡、粘附和迁移等多种细胞过程的影响,因此在许多生物过程中发挥重要作用。一些 ALK 与多种疾病有关,包括肿瘤发生和免疫疾病,这表明这些受体可以作为药物靶点。

TGF-β receptors (Transforming growth factor-β receptors) are single pass serine/threonine kinase receptors. Transforming growth factor beta (TGF-beta) is a member of a large family of pleiotropic cytokines that are involved in many biological processes, including growth control, differentiation, migration, cell survival, adhesion, and specification of developmental fate, in both normal and diseased states. TGF-beta superfamily members signal through a receptor complex comprising a type II and type I receptor, both serine/threonine kinases.

The type I receptors, referred to as activin receptor-like kinases (ALK), lie at the epicenter of the signaling cascade as they transduce TGF-beta signals to intracellular regulators of transcription known as Smad proteins. ALKs possess an extracellular binding domain, a transmembrane domain, a GS domain that serves as the site of activation by type II receptors, and a kinase domain that activates downstream signaling molecules. ALKs mediate the effect of TGF-beta superfamily on a variety of cellular processes such as proliferation, differentiation, apoptosis, adhesion and migration, and therefore play important roles in many biological processes. Some ALKs have been implicated in several disorders, including tumorigenesis and immune diseases, suggesting that these receptors can be used as drug targets.

共 6种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
KQFK

KQFK 是源自 TSP-1 的肽 KRFK (MS-U19273) 的无活性对照,而 KRFK 可激活 TGF-β。

162290-88-2
Control
KQFK
KQFK TFA

KQFK TFA 是 KQFK(MS-E79117)的 TFA 盐形式,也是 KRFK(MS-U19273)的无活性对照,而 KRFK 是一种源自 TSP-1 且可激活 TGF-β 的肽。

Control
99.55%
KQFK TFA
L-Seryl-L-leucyl-L-leucyl-L-lysine
SLLK

L-Seryl-L-leucyl-L-leucyl-L-lysine(SLLK)是 LSKL(MS-E92920)的对照肽。

464924-27-4
Control
L-Seryl-L-leucyl-L-leucyl-L-lysine
SLLK, Control Peptide for TSP1 Inhibitor

SLLK 是 LSKL 的对照肽,即 TSP1 抑制剂的对照肽。

2918768-29-1
Control
99.70%
SLLK, Control Peptide for TSP1 Inhibitor
SLLK, Control Peptide for TSP1 InhibitorTFA

SLLK, Control Peptide for TSP1 Inhibitor (TFA) 是血小板反应蛋白抑制剂 (TSP-1) LSKL 的对照肽。

Control
99.83%
SLLK, Control Peptide for TSP1 InhibitorTFA
HCTZ-CH2-HCTZ
双氢氯噻嗪杂质C

HCTZ-CH2-HCTZ 是 HCTZ (MS-B09084) 的异构体,而 Hydrochlorothiazide (HCTZ) 是一种具有口服活性的噻嗪类利尿药,可抑制 TGF-β/Smad 转化信号通路。

402824-96-8
Control
双氢氯噻嗪杂质C

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础